Tag: cycler (Page 3 of 55)

What Are We Expecting: The IPN Forthcoming?

As I have been blogging about, I am in the throes of entry into the world of IPN. The refrigerator to cool the mixture is due to arrive tomorrow from Lowe’s. We expect to hear soon from Pentec to receive the training they provide for IPN usage. Soon to follow this should be the actual receipt of our weekly allotment of IPN-fused dialysis bags.

In preparation for our IPN gig, I quizzed Perplexity about the nuts and bolts of IPN actual use with the following Prompt and results. Doesn’t seem to be all that complicated after all.

Prompt: What are the nuts and bolts of actually using IPN from Pentec?

The nuts and bolts of actually using IPN (Intraperitoneal Nutrition) from Pentec Health involve several key steps and considerations to ensure safe and effective therapy for peritoneal dialysis patients who need additional protein supplementation:

What is IPN from Pentec?

  • IPN is a nutritional therapy that adds protein directly into the peritoneal dialysis fluid (dialysate) by replacing some of the usual dextrose with protein. This helps replenish protein losses that dialysis patients experience and supports nutritional status without requiring oral intake123.

How IPN is Prepared and Delivered

  • Pentec Health prepares customized IPN bags based on the patient’s specific dialysis regimen and nutritional needs. A Pentec nurse or pharmacist compounds the sterile bags by adding protein to the patient’s cycler or CAPD bag, removing some dextrose to maintain fluid balance14.
  • The IPN bags are shipped weekly to the patient’s home and must be refrigerated between 36-46°F. Pentec provides a refrigerator for storage. Patients are instructed to inspect bags for damage or discoloration immediately upon delivery and before use25.

Administration of IPN

  • IPN is typically administered daily at home as a replacement for one of the patient’s regular exchange bags, either manually or via cycler. Patients are trained on how to handle and infuse the bags safely25.
  • The IPN bag is usually the first bag on the cycler machine or hung to replace one exchange5.

Monitoring and Clinical Support

  • Pentec provides a clinical case manager and registered dietitians who work closely with the patient’s nephrologist and dialysis clinic. They:
    • Confirm patient eligibility and customize the IPN prescription.
    • Monitor nutritional status through labs (e.g., albumin levels) and clinical assessments.
    • Adjust therapy as needed based on patient response.
    • Help manage any side effects, such as dehydration, which can occur if IPN causes additional ultrafiltration14.
  • Fluid removal goals during dialysis are adjusted carefully. For example, for IDPN (similar therapy for hemodialysis), 75-80% of the total volume is suggested to be removed; similar judgment applies to IPN fluid management14.

Duration and Goals of Therapy

  • The length of IPN therapy varies per individual and depends on nutritional needs and response. Typically, improvements in appetite, strength, and energy are expected within a few months2.
  • Once protein levels normalize, clinicians may consider discontinuing or pausing therapy to see if nutrition can be maintained independently1.

Insurance and Financial Considerations

  • IPN therapy is covered by many commercial and Medicaid insurance plans. Pentec Health handles billing directly and offers flexible payment options and assistance programs if needed2.

Summary Table of Key Steps in Using Pentec IPN

StepDescription
PrescriptionNephrologist and dietitian determine need; PD nurse completes IPN prescription form with Pentec CCM
PreparationPentec compounds sterile, patient-specific IPN bags by adding protein and removing dextrose
Delivery & StorageWeekly home shipment; refrigerate at 36-46°F; inspect bags for damage or discoloration
AdministrationReplace one PD exchange bag daily with IPN bag; use cycler or manual exchange
Monitoring & SupportRegular lab tests (albumin), clinical assessments, therapy adjustments by Pentec clinical team
Side Effect ManagementWatch for dehydration or other issues; clinical team intervenes as needed
DurationIndividualized; often several months until nutritional goals met
Insurance & BillingPentec handles insurance; offers payment plans and assistance

In essence, using Pentec’s IPN involves a coordinated clinical approach with personalized sterile nutrition bags integrated into the patient’s peritoneal dialysis routine, supported by ongoing clinical monitoring and patient education to optimize nutritional outcomes safely and effectively1245.

  1. https://pentechealth.com/idpnipn/
  2. https://pentechealth.com/media/hi4hdpco/23pen01008-0124-ipn-patient-brochure.pdf
  3. https://pentechealth.com/newsroom/idpn-ipn-nutrition-therapy-for-dialysis-patients-what-s-the-difference/
  4. https://pentechealth.com/renal-nutrition-faqs/
  5. https://pentechealth.com/media/lxgjflej/23pen01071_ipn-home-therapies.pdf
  6. https://pentechealth.com
  7. https://pentechealth.com/media/bfolvrox/pentechealth_guide-to-idpn.pdf
  8. https://www.pharmko.com/blog/understanding-intraperitoneal-nutrition-ipn-and-its-uses
  9. https://pentechealth.com/dialysis-clinics/
  10. https://pentechealth.com/media/g0kbui5t/patient-and-hcp-proplete-info-sheets.pdf
  11. https://www.pharmko.com/blog/how-ipn-supports-patients-with-severe-malnutrition
  12. https://pentechealth.com/clinical-assistance-program/
  13. https://www.pharmko.com/blog/how-to-monitor-and-adjust-ipn-for-optimal-patient-outcomes
  14. https://pentechealth.com/patient-information/
  15. https://pentechealth.com/patient-education/
  16. https://www.kidneywi.org/wp-content/uploads/2020/11/How-IDPN-and-IPN-Can-Benefit-Your-Patinets.pdf
  17. https://www.reddit.com/r/dietetics/comments/17f4zgj/renal_question_idpn/

Peritoneal Dialysis and Protein Loss

This blog follows along with my recent prescription to incorporate more protein in my diet to raise my albumin to acceptable levels. It is currently in the mid-threes, where it should be a minimum of five. I also have the lingering question of cause and effect of protein loss and my current tiredness and general lack of git up and go.

To look into this aspect of our dialysis burden, I turned to Perplexity with the following Prompt and result – spoiler – they go hand in glove:

Prompt: Is it possible that peritoneal dialysis reduces body protein to the extent that the patient is weak, gets winded after the slightest exertion, etc?

Peritoneal dialysis (PD) can contribute to significant protein loss, which may lead to muscle wasting, weakness, and fatigue. Here’s a detailed analysis:

Protein Loss in Peritoneal Dialysis

  • PD patients lose 5–7 grams of protein daily through dialysate, primarily albumin217.
  • This loss occurs because the peritoneum allows serum proteins to leak into the dialysis fluid during exchanges27.

Mechanisms Linking Protein Loss to Weakness

  1. Muscle Wasting (Sarcopenia)
    • Chronic protein loss exacerbates protein-energy wasting, reducing muscle mass and strength37.
    • Uremia, inflammation, and hormonal imbalances further accelerate muscle breakdown34.
  2. Fatigue and Exertional Limitations
    • Protein depletion impairs muscle repair and energy metabolism, causing fatigue and breathlessness during minimal exertion456.
    • Anemia (common in dialysis) reduces oxygen delivery, worsening fatigue6.
  3. Inflammation and Metabolic Dysfunction
    • Chronic inflammation from PD increases catabolism (muscle breakdown)37.
    • Acidosis and insulin resistance further disrupt protein synthesis34.

Contributing Factors

  • Fluid Overload: Exacerbates protein loss and inflammation7.
  • Inadequate Nutrition: PD patients require 1.3g/kg/day of protein to offset losses1. Failure to meet this accelerates muscle loss.
  • Physical Inactivity: A vicious cycle where fatigue reduces activity, further diminishing muscle mass45.

Management Strategies

  • Nutritional Intervention: High-protein diets (e.g., eggs, lean meats) to counter losses13.
  • Exercise: Resistance training preserves muscle mass and reduces fatigue56.
  • Volume Control: Optimizing fluid removal minimizes overhydration-related protein leakage7.

Conclusion

Yes, peritoneal dialysis can deplete body proteins sufficiently to cause weakness and exertional intolerance. This stems from direct protein loss, compounded by inflammation, metabolic dysregulation, and inadequate nutritional compensation. Addressing protein intake, volume status, and physical activity is crucial to mitigate these effects2137.

  1. https://www.dpcedcenter.org/wp-content/uploads/2021/02/Protein-and-Dialysis.pdf
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC3082414/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC12005912/
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC2582327/
  5. https://www.nhs.uk/tests-and-treatments/dialysis/side-effects/
  6. https://www.dpcedcenter.org/news-events/news/conquering-dialysis-fatigue/
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC9178188/
  8. https://www.sciencedirect.com/science/article/pii/S0085253815324741
  9. https://onlinelibrary.wiley.com/doi/10.1111/sdi.13194
  10. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.653807/full
  11. https://www.mdpi.com/2077-0383/12/7/2670
  12. http://www.davita.com/treatment-services/peritoneal-dialysis/protein-and-your-peritoneal-dialysis-diet
  13. https://advancingdialysis.org/peritoneal-dialysis/nutritional-status-concerns-for-peritoneal-dialysis-patients/
  14. https://www.kidney.org/kidney-topics/getting-more-protein-while-dialysis
  15. https://homedialysis.org/news-and-research/blog/547-muscle-stiffness-in-dialysis-patients-tips-to-prevent-and-overcome
  16. https://onlinelibrary.wiley.com/doi/10.1155/2014/614846

Probability I Will Go On HHD?

Been mullin’ over the comment in my last dialysis team meeting that I may have to start Hemo of some form in the near future because PD, at some point, wears out. I accept this statement as a fact, but it bears validation.

As per usual, I turned to Perplexity with the following Prompt and results. Spoiler again: not so soon, it seems.

Prompt: 86-year-old male. went on PD Aug 28, 2022. What’s the probability i will need to go on HHD by the end of 2026?

Based on available data, the probability that an 86-year-old male who started peritoneal dialysis (PD) on August 28, 2022, will need to switch to hemodialysis (HD) by the end of 2026 is relatively low, but not negligible. The main reasons elderly patients on PD switch to HD are peritonitis, sepsis, or inadequate dialysis123.

Technique Survival Rates (Probability of Staying on PD)

  • 1-year technique survival: 94.8–97.9%
  • 2-year technique survival: 90.6%
  • 3-year technique survival: 81.5–85.3%
  • 4-year technique survival: 71%
  • 5-year technique survival: 71.7% (in one study)12

These rates mean that, on average, about 70–80% of elderly patients who start PD are still on PD (not switched to HD) at 3–4 years after initiation. Your timeline (from August 2022 to end of 2026) is just over 4 years.

Risk Factors for Needing to Switch to HD

  • Peritonitis and/or sepsis are the most common causes for switching from PD to HD in elderly patients12.
  • Inadequate dialysis is another important reason1.
  • Advanced age, comorbid diseases, low albumin, and low urine output at PD initiation increase risk of complications and mortality, but not necessarily technique failure134.
  • Technique survival (the probability of remaining on PD) is not significantly affected by age alone in most studies4.

Mortality vs. Technique Failure

  • Mortality rates are high in elderly PD patients; survival rates at 3 years are around 50%, and at 5 years drop to 17–36% for those over 751235.
  • Most elderly patients who leave PD do so because of death, not technique failure (i.e., not because they need to switch to HD)23.

Summary Table: Probability of Remaining on PD

Years on PDTechnique Survival Rate (Elderly)Probability of Needing HD (Cumulative)
195–98%2–5%
291%9%
382–85%15–18%
471%29%
571–72%28–29%

Estimates based on studies of elderly PD patients, most of whom are younger than 86, so your personal risk may be slightly higher due to advanced age123.

Conclusion

By the end of 2026 (a little over 4 years on PD), the probability that you will need to switch to HD is roughly 25–30%. The majority of elderly patients who leave PD do so because of death, not technique failure. Your individual risk may be higher if you have frequent peritonitis, low albumin, or significant comorbidities1234.

If you have been stable on PD so far, your chance of needing to switch to HD by the end of 2026 is less than one in three, but ongoing monitoring and good infection prevention are very important12.

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC4449459/
  2. https://indianjnephrol.org/clinical-characteristics-patient-and-technique-survival-in-elderly-patients-on-peritoneal-dialysis/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC10557534/
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC8824377/
  5. https://www.renalfellow.org/2018/09/19/what-are-survival-rates-for-dialysis-patients/
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC2649113/
  7. https://med.stanford.edu/news/all-news/2024/08/dialysis-older.html
  8. https://www.asn-online.org/education/distancelearning/curricula/geriatrics/Chapter20.pdf
  9. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2730766
  10. https://journals.lww.com/md-journal/fulltext/2018/08310/peritoneal_dialysis_in_older_adults__evaluation_of.23.aspx

Question Is: How fast does IPN Work?

My wife and I are in discussions about the new routine we’re about to embark upon, that of IPN. We debated how long it takes for it to take effect, so to speak. Is a day, a week, a month, or longer.

To obtain a definitive answer to this question, I turned to Perplexity with the following Prompt and response. Spoiler – it will take some time.

Prompt: How rapidly does IPN take effect? days, weeks, months?

Intraperitoneal Nutrition (IPN) typically takes several weeks to months to show measurable effects in patients on peritoneal dialysis. Here’s what the evidence and clinical experience indicate:

  • Improvements in nutritional markers such as serum albumin and prealbumin—key indicators of protein status and overall nutrition—are generally observed after several months of IPN therapy.
  • Positive changes in strength, physical health, and appetite are commonly reported by patients, but these also tend to develop over the course of months rather than days or a few weeks.
  • Clinical monitoring is usually performed at least quarterly (every three months), and the goal is often to see an albumin increase to around 4.0 g/dL. The time to reach this target varies, but most patients require ongoing therapy for a minimum of 3 months, with many continuing for longer depending on their response and nutritional needs.
  • Incremental improvements—such as a 0.2 g/dL increase in albumin—are considered clinically meaningful and can be seen during this period, with about 70% of patients in one cohort showing such improvements within several months.
  • If there is no significant improvement after 3 to 6 months, clinicians may consider discontinuing IPN and exploring alternative interventions.

In summary:
Most patients will not see immediate effects within days; meaningful improvements typically require several weeks to months of consistent IPN therapy. The exact timeline can vary based on the individual’s baseline nutritional status, the degree of malnutrition, and how well they tolerate and absorb the therapy.

IPN and Me

一百年后,这一切都无关紧要。

First off, IPN is IntraPertoneal Nutrition. I have recently been placed in the hopper to receive this treatment, which is provided byPenTec Health.

Pentec Health is a nationwide leader in clinical nutrition and specialty pharmacy services, with over 40 years of experience serving patients with complex, chronic health conditions. The company was founded in 1983 as “PENtech Infusions,” initially focusing on meeting the needs of dialysis patients and those with severe pain or spasticity. In 2006, it was renamed Pentec Health to reflect its broader healthcare offerings.

So we all can learn more about IPN, I turned to Perplexity with the following Prompt and results. I have one of the many Chinese curses, to wit, “In 100 years this won’t matter!” is lead graphic in Chinese.

Prompt: For a patient on pd who has just been prescribed IPN treatment by his neproholigust, what’s in store for him?

A patient on peritoneal dialysis (PD) who has just been prescribed Intraperitoneal Nutrition (IPN) by their nephrologist can expect several key changes and supports in their care routine:

What is IPN and Why Is It Prescribed?

  • IPN is a specialized nutritional therapy designed for PD patients who are experiencing or are at risk for malnutrition, particularly due to the significant protein losses (5–15 grams daily) that occur during dialysis123.
  • It involves adding amino acids (protein building blocks) directly into the dialysis solution (dialysate), which is then infused into the peritoneal cavity during a regular dialysis exchange1452.

What Will the Patient Experience?

  • Customized Nutrition: The IPN solution is tailored to the patient’s individual nutritional needs, based on lab results and clinical assessments. It typically includes amino acids and may also contain other nutrients, such as vitamins and minerals1453.
  • Administration: The patient will substitute one of their usual PD dialysate bags with an IPN bag each day (or as prescribed). This is usually done at home, with training and support from a nurse or pharmacist52.
  • Home Support: Patients receive regular home deliveries of the IPN solution and necessary supplies, plus ongoing training and monitoring from healthcare professionals52.
  • Monitoring: The patient’s nutritional status (e.g., serum albumin levels, body weight) will be closely monitored, typically with blood tests every few months. Adjustments to the IPN formula may be made as needed1452.
  • Team-Based Care: The patient will work closely with their nephrologist, a renal dietitian, PD nurses, and possibly a case manager to ensure the therapy is effective and safe145.

Expected Benefits

  • Improved Nutritional Status: IPN helps restore protein and calorie balance, increasing important markers like albumin and prealbumin, which are linked to better health outcomes and lower hospitalization rates1672.
  • Better Physical Health: Many patients report improved appetite, energy, and muscle strength after starting IPN167.
  • Reduced Complications: By addressing malnutrition, IPN can decrease the risk of infections (such as peritonitis), hospitalizations, and other complications common in PD patients173.

Possible Side Effects and Considerations

  • Generally Well Tolerated: Most patients do not experience significant side effects, but some may notice mild gastrointestinal symptoms (e.g., nausea, fullness), especially if the infusion rate is too high46.
  • Fluid Management: Because IPN adds fluid to the body, careful monitoring of fluid balance is essential to avoid dehydration or overhydration. Adjustments in the dialysis prescription may be needed45.
  • Duration of Therapy: The length of time a patient remains on IPN varies. Therapy may be paused or discontinued if the patient’s nutritional markers improve and stabilize4.

Summary Table: What’s in Store for a PD Patient Starting IPN

AspectWhat to Expect
Therapy TypeAmino acids/nutrients added to PD dialysate
AdministrationAt home, replaces one or more daily exchanges
SupportHome delivery, nurse/pharmacist training, 24/7 support
MonitoringRegular labs, ongoing team-based adjustments
BenefitsImproved nutrition, energy, reduced complications
Side EffectsRare, mostly mild GI symptoms, fluid balance monitored
DurationIndividualized, based on response and lab results

In summary:
A patient starting IPN can expect a personalized, home-based nutritional therapy designed to improve their protein levels and overall health, with regular support and monitoring from a multidisciplinary care team. This intervention is generally well tolerated and can significantly improve outcomes for malnourished PD patients14652.

To complete my background in the need for IPN, I’ve embedded the cover letter my Neprologist, Dt Turner submitted with the application.

  1. https://www.pharmko.com/blog/ipn-for-peritoneal-dialysis-explained
  2. https://www.pharmko.com/blog/what-is-ipn-for-peritoneal-dialysis
  3. https://brooksinfusion.com/ipn/
  4. https://pentechealth.com/idpnipn/
  5. https://pcacorp.com/nutririte-home-idpn-ipn/
  6. https://www.pharmko.com/blog/intraperitoneal-nutrition-for-health
  7. https://www.pharmko.com/blog/how-ipn-supports-patients-with-severe-malnutrition
  8. https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/peritoneal-dialysis/eating-nutrition
  9. https://www.kidneywi.org/wp-content/uploads/2020/11/How-IDPN-and-IPN-Can-Benefit-Your-Patinets.pdf
  10. https://pubmed.ncbi.nlm.nih.gov/9915292/

Friday’s Off Topic Day: Origin of R&B

As the title suggests, from time to time, I go off the topic of my dialysis journey. Today is no exception. I’m going to relate to you a little of the background from my formative years, the mid-fifties, when I was 15-17, and a sophomore-senior in high school.

Quite often during the time frame suggested, a small group of boys who were also into fast cars would meet in a friend’s garage (Paul Hinton to be exact) where we would discuss cars, girls, drink beer, play poker, and listen to radio station WLAC Nashville. Guys would drop in after dates, with some bringing their female friends with them. All through this, WLAC took front and center. So what’s with WLAC of yore? WLAC was, at the time, at the front of R&B. It brought R&B to the public’s attention and ours. In short, we listened to artists and music long before it reached the airwaves in Springfield, Ohio. WolfMan Jack hadn’t been invented, but WLAC had. Since WLAC played such a pivotal role in my early music listening, it is worth looking back to see where I am now. I quizzed Perplexity with the following Prompt and results. Following at bottom is a clip from Bo Diddley on how he got started. He was one of the artists on WLAC early on. I also inserted a Howlin’ Wolf rendition to give you a flavor of the tunes coming across from WLAC at the time.

Prompt: In the 50s, there was a station in Nashville, WLAC, that played real R&B sponsored by “white rose petroleum jelly” Tell us about this

John R American radio disc jockey who attained fame in the ...
WLAC - Wikipedia
How America Got Its First Black Radio Station - Atlas Obscura
Radio, TV and the Nashville R&B Scene (Part Two) - E. Mark ...
Bill "Hoss" Allen - Wikipedia

WLAC and Its Pioneering R&B Broadcasts in the 1950s

WLAC was a Nashville, Tennessee, powerhouse AM radio station (1510 AM) that became legendary in the 1950s for broadcasting rhythm and blues (R&B) music across much of the United States, especially at night when its 50,000-watt clear-channel signal reached up to 28 states, parts of Canada, and the Caribbean. WLAC played a crucial role in introducing Black R&B music to both Black and white audiences during a time of deep segregation and limited access to such music on mainstream radio.

The WLAC R&B Format

  • Programming: Starting in the mid-1940s and peaking through the 1950s and 1960s, WLAC’s nighttime airwaves were dominated by a quartet of white DJs—Gene Nobles, John Richbourg (known as “John R.”), Bill “Hoss” Allen, and Herman Grizzard—who played records by Black artists such as Chuck Berry, Fats Domino, Little Richard, Muddy Waters, and Etta James.
  • Audience: The station’s management deliberately targeted Black listeners, knowing their signal reached 80% of Black homes in the country at night. However, the shows also attracted a large number of white teenagers, many of whom were hearing authentic R&B for the first time.
  • Cultural Impact: WLAC’s broadcasts helped lay the groundwork for the rock and roll explosion, influencing future musicians and helping to bridge racial divides in American popular music.

Sponsorship and “White Rose Petroleum Jelly”

  • Advertising Approach: The DJs’ shows were heavily sponsored by products marketed to Black consumers, many of which were sold via mail order and promoted with colorful, sometimes humorous, and often suggestive on-air pitches.
  • White Rose Petroleum Jelly: Among the most famous sponsors was “White Rose Petroleum Jelly,” a brand of white petroleum jelly. The DJs would read lively and sometimes double-entendre-filled commercials for this product, joking about its many supposed uses. The playful, sometimes risqué nature of these ads became part of the station’s mystique and appeal, especially among teenagers who felt they were part of a secret, subversive listening club.
  • Other Products: Alongside White Rose Petroleum Jelly, the station also advertised products like Royal Crown Hair Pomade and even live baby chicks, all targeting the station’s core late-night audience.

Business Model and Legacy

  • Mail-Order Economy: Much of the station’s revenue came from mail-order businesses, such as Randy’s Record Mart, which became the nation’s largest mail-order record seller thanks to WLAC’s reach and influence.
  • Social Change: While the DJs and station management profited from Black music and audiences, many Black musicians appreciated the exposure and career opportunities WLAC provided, even as the station’s aggressive product promotion sometimes took advantage of its listeners.
  • Enduring Influence: WLAC’s R&B shows were instrumental in breaking down racial barriers in American music, inspiring countless musicians (including Bob Dylan and members of The Band) and helping to usher in the rock and roll era.

“During the hours not sponsored by record shops, WLAC featured a whole slew of wonderful commercials for such things as… ‘live baby chicks,’ ‘Royal Crown Hair Dressing’ and ‘White Rose Petroleum Jelly.’ The disc jockeys used to have a lot of fun mentioning creative uses for that versatile substance, many with double entendre meanings.”

Summary Table: WLAC R&B Era Highlights

FeatureDetails
LocationNashville, Tennessee (not Memphis)
Era1940s–1970s (peak R&B influence in 1950s–60s)
Signal Reach50,000 watts; up to 28 states, Canada, Caribbean at night
Key DJsGene Nobles, John Richbourg (“John R.”), Bill “Hoss” Allen, Herman Grizzard
AudiencePrimarily Black listeners, but also white teenagers across the eastern U.S.
Notable SponsorsWhite Rose Petroleum Jelly, Royal Crown Hair Pomade, Randy’s Record Mart, live chicks
LegacyBroke racial barriers, fueled R&B/rock crossover, influenced generations of musicians

WLAC’s nightly R&B programming, with its iconic product pitches for items like White Rose Petroleum Jelly, stands as a pivotal chapter in American radio and music history, shaping tastes and breaking down social barriers in the mid-20th century.

Status of Wearable Glucose Monitors for Dialysis Patients

Since I am no longer taking the oral medication Januvia, my GP suggested I keep a close eye on my glucose to make certain it remains within limits. You may recall from several previous blogs you can search on herein, that in the past I have paid for wearable glucose monitors myself, then Medicare started to pay, and I used one for about two years. Then, somehow, the FDA got involved and stated that the devices had not been cleared for those of us on dialysis. Medicare pulled support for the devices, leaving me to go back to the old school of finger pricks. That’s where I am again. Forty years as a diabetic and nothing’s changed.

So it is of interest to me where this all now stands. I quizzed Perplexity with the following Prompt and results:

Continuous glucose monitors on the rise after FDA approval
Company's new wearable device will help diabetics eat right ...
Surge in FDA Approvals for Diabetes Devices and Product Advances
Abbott finally gets FDA greenlight for FreeStyle Libre 2 ...

Prompt: FDA Approval Status of Wearable Glucose Monitors for Dialysis Patients

No wearable continuous glucose monitors (CGMs) are specifically FDA approved for use in patients on dialysis or those with end-stage renal disease (ESRD). This is a key distinction: while several CGMs are FDA approved for people with diabetes, their use in the dialysis population remains off-label.

Details from Recent Research and FDA Statements

  • According to diabetes technology experts and recent research, “these CGM devices… are not yet FDA approved for patients with ESRD on dialysis” due to the medical complexity of this population and their exclusion from most clinical trials111.
  • Studies have shown that factory-calibrated CGMs (such as the Dexcom G6-Pro) can provide reasonably accurate glucose readings in dialysis patients, but these studies are not large enough to support FDA approval for this specific use111.
  • The FDA has not cleared or approved any smartwatch or smart ring that measures glucose non-invasively (without skin piercing), for any population, including those on dialysis29.

Currently Approved CGMs

  • The Dexcom G7, Abbott FreeStyle Libre 14-Day, and Eversense E3 are all FDA approved for people with diabetes, but not specifically for those on dialysis5671012.
  • Over-the-counter CGMs such as Dexcom Stelo and Abbott Lingo have recently been cleared, but these are not indicated for people using insulin or those with problematic hypoglycemia, and there is no mention of approval for dialysis patients38913.

Off-Label Use in Dialysis

  • Despite the lack of specific FDA approval, many clinicians and patients use CGMs off-label in the dialysis population due to their potential benefits and reasonable accuracy as shown in pilot studies111.
  • If you are considering a CGM and are on dialysis, it is essential to discuss this with your healthcare provider, as they can help interpret the readings and manage any device limitations111.

Summary Table: FDA Status of Wearable Glucose Monitors for Dialysis

Device TypeFDA Approved for General Diabetes?FDA Approved for Dialysis/ESRD?Notes
Dexcom G6/G7YesNoOff-label use in dialysis studied61011
Abbott FreeStyle LibreYesNoOff-label use in dialysis studied510
Eversense E3 (implantable)YesNoNo specific dialysis approval710
Dexcom Stelo (OTC)Yes (non-insulin users)NoNot for insulin users or problematic hypoglycemia389
Abbott Lingo (OTC)No (wellness only)NoNot for diabetes management8
Smartwatches/Smart RingsNoNoNo FDA approval for glucose measurement29

Key Takeaway

No wearable glucose monitor is FDA approved specifically for people on dialysis. However, off-label use of established CGMs is common, and emerging research supports their reasonable accuracy in this population, though further studies and regulatory review are needed before formal approval111. Always consult your healthcare provider before starting CGM use if you are on dialysis.

  1. https://newsroom.uvahealth.com/2022/06/29/off-shelf-glucose-monitors-prove-accurate-for-dialysis-patients/
  2. https://www.fda.gov/medical-devices/safety-communications/do-not-use-smartwatches-or-smart-rings-measure-blood-glucose-levels-fda-safety-communication
  3. https://www.ajmc.com/view/fda-approves-first-over-the-counter-continuous-glucose-monitor
  4. https://texasdiabetes.com/fda-approves-new-otc-continuous-glucose-monitor-cgm/
  5. https://www.abbott.com/corpnewsroom/products-and-innovation/freestyle-libre-14-day.html
  6. https://investors.dexcom.com/news/news-details/2022/Dexcom-G7-Receives-FDA-Clearance-The-Most-Accurate-Continuous-Glucose-Monitoring-System-Cleared-in-the-U.S/default.aspx
  7. https://www.fda.gov/medical-devices/eversense-e3-continuous-glucose-monitoring-system-p160048s016
  8. https://www.goodrx.com/classes/medical-supplies-and-devices/otc-continuous-glucose-monitor-faqs
  9. https://www.theregreview.org/2024/09/25/diaz-reducing-barriers-to-glucose-monitoring/
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC10012164/
  11. https://www.techtarget.com/virtualhealthcare/news/366597498/Continuous-Glucose-Monitors-Effective-RPM-for-ESRD-Patients
  12. https://www.ncbi.nlm.nih.gov/books/NBK279046/
  13. https://www.cardiometabolichealth.org/the-new-era-of-continuous-glucose-monitoring-cgm-expanding-access-and-improving-outcomes/

Regarding Peritoneal Transport Function: What is better, high or low?

The header captures the thrust of this blog. Is it better to have a stomach lining with high or low transport? I turned to Perplexity to address this question with the following prompt and response. Spoiler, less is better!

Prompt: In peritoneal dialysis, what is better, a high or low transport function, especially regarding dialysis longevity

The best peritoneal transfer function for longevity on the peritoneal lining in peritoneal dialysis (PD) is generally a low transport status—that is, a low peritoneal solute transfer rate (PSTR) or low permeability—rather than a high transport status.

Why Low Transport Is Preferable

  • High Transport Status and Risks:
    • High transport status is associated with increased mortality risk, more comorbid diseases, and a higher likelihood of technical failure (failure to continue PD due to inadequate dialysis or complications)1.
    • High transporters tend to have lower ultrafiltration (fluid removal) and are at greater risk for fluid overload, which can lead to hypertension and cardiac dysfunction1.
    • Over time, the peritoneal membrane in long-term PD patients often becomes more permeable (higher transport), which is linked to worsening functional and morphological states of the membrane, including increased fibrosis and decreased ultrafiltration capacity12.
  • Low Transport Status Benefits:
    • Patients with low transport status generally maintain better ultrafiltration and have less risk of overhydration.
    • Lower transport rates are associated with better preservation of the peritoneal membrane and a lower risk of encapsulating peritoneal sclerosis (EPS), a rare but serious complication of long-term PD23.
    • Studies show that as PD continues, solute transport tends to increase and ultrafiltration declines, but those who start with or maintain lower transport rates have better outcomes12.

Impact of Peritonitis and Glucose Exposure

  • Peritonitis:
    • Frequent peritonitis episodes accelerate the increase in small solute transport and decrease in ultrafiltration, further compromising the peritoneal membrane’s longevity4.
  • Glucose Exposure:
    • Long-term exposure to glucose-based dialysis solutions causes structural and functional alterations, including fibrosis and vasculopathy, which are more pronounced in patients with higher transport rates23.
    • These changes lead to reduced free water transport and, ultimately, ultrafiltration failure23.

Summary Table

Transport StatusUltrafiltrationMortality RiskMembrane LongevityRisk of Fluid Overload
HighLowerHigherWorseHigher
LowHigherLowerBetterLower

Conclusion

For longevity of the peritoneal lining in PD, low transport status is preferable because it is associated with better ultrafiltration, lower mortality, and a reduced risk of serious complications like encapsulating peritoneal sclerosis12. High transport status is linked to worse outcomes and more rapid deterioration of the peritoneal membrane. A little filet is always better than lots of lettuce!

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC7428920/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC9096116/
  3. https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2024.1322493/full
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC4934441/
  5. https://pubmed.ncbi.nlm.nih.gov/8285200/
  6. https://www.sciencedirect.com/science/article/abs/pii/S0272638612808146
  7. https://www.sciencedirect.com/science/article/pii/S0085253815308607
  8. https://www.mdpi.com/2077-0375/12/3/276
  9. http://ispd.org/NAC/wp-content/uploads/2010/11/Modalities-PD-Devita-May-2011.pdf
  10. https://www.ncbi.nlm.nih.gov/books/NBK72297/

Transport Function Review

While I have written about the central importance of the peritoneal lining to peritoneal dialysis, since mine is now somewhat under review and contention, it is appropriate to review this topic.

I turned to a new for me AI engine that specializes in academic research, Consenius.app, with the following prompt and results concerning this topic:

Prompt: Discuss the transport function in layman’s terms and how it may “fatigue,” leading to the need for HD.

Understanding Transport Function in Peritoneal Dialysis

Transport function in peritoneal dialysis (PD) refers to how well the lining of the abdomen (the peritoneal membrane) can move waste products and extra water from the blood into the dialysis fluid. This process is essential for keeping the body balanced when the kidneys are not working.

What Does “Fatigue” of Transport Function Mean?

Over time, the peritoneal membrane can become less effective at this job. This “fatigue” means the membrane doesn’t move wastes and water as efficiently as before. Reasons for this can include changes in the membrane itself, such as thickening or scarring, or the body absorbing the dialysis fluid too quickly. When this happens, patients may notice more swelling, higher blood pressure, or feel generally unwell because the dialysis is not removing enough fluid or toxins.

Why Might This Lead to Switching to Hemodialysis?

PD can no longer keep up with the body’s needs when the peritoneal membrane’s transport function is too “tired” or worn out. At this point, doctors may recommend switching to hemodialysis (HD), which uses a machine to clean the blood more directly and does not rely on the peritoneal membrane. This switch is often necessary to maintain health and prevent complications like fluid overload or toxin buildup910.

Key Points

  • The peritoneal membrane acts as a natural filter in PD.
  • Over time, this filter can become less effective—this is “transport function fatigue.”
  • When PD no longer works well, patients may need to switch to HD for better waste and fluid removal910.

In summary:
Transport function in PD can “wear out” over time, making the treatment less effective and leading to a need for hemodialysis.

Rationalizing Medications

This past Wednesday, I met with my GP, followed by a monthly meeting with my Dialysis Team. For the meeting with our GP, I had a specific agenda laid out as I did with the Dialysis Team, and took the lead. In both cases, one of the THREE items on our (I say our, because my wife, as my Caregiver, was very involved in setting up the agenda for the meetings) agenda was to review the top three drugs I was taking with the thought in mind to reduce or do away with them.

The drug handout we authored is embedded below:

I am pleased to report that after some discussion, I am no longer taking Januvia for diabetes with the caveat that we’re going to watch my glucose closely. My dialysis doctor stated that the majority of her insulin-taking patients take no oral diabetic medicine. Disposing of hydro… was straightforward. My GP strongly suggested halving my statin medication, while my dialysis doctor was Ok with dropping it. As a result, I’m now taking 1/2 of what I was before the meeting.

As a result of going into the meeting with a plan and our ducks in a row, we dropped two meds altogether and reduced the third by 50%, intending to drop it entirely in the future if my cholesterol and triglyceride readings do not go bananas. A win for all of us.

« Older posts Newer posts »